GVR Report cover Clinical Microbiology Market Size, Share & Trends Report

Clinical Microbiology Market Size, Share & Trends Analysis Report By Product, By Application (Bloodstream, Respiratory, Gastrointestinal, Periodontal, STD, UTI), By Region, And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-1-68038-142-9
  • Number of Pages: 94
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2015
  • Industry: Healthcare

Report Overview

The global clinical microbiology market size was valued at USD 9.1 billion in 2016 and is expected to develop at a CAGR of 6.7% over the forecast period. Constantly rising incidence of infectious diseases is driving market growth.

U.S. clinical microbiology market size

Infectious diseases are primarily diagnosed using clinical tests. According to the Centers for Disease Control and Prevention (CDC), around 9,421 new cases of tuberculosis, 51,455 new cases of salmonella, 33,461 new cases of Lyme disease, and 433 new cases of meningococcal disease were registered in U.S. in 2014.

Similarly, according to the American Cancer Society, around 1,688,780 new cases of cancer were diagnosed in U.S. in 2017. Thus, high prevalence of diseases where clinical tests are used as one of the major diagnostic tools is expected to augment market growth in future. Sudden outbreaks of Ebola, Zika, and other contagious pathogens are also contributing to rising prevalence of infectious diseases.

As per an article published in the Journal of Clinical Microbiology, there is a shortage of trained and skilled professionals in medical and microbiological laboratories for processing and interpreting samples and specimens. Moreover, there has been a steep decline in the number of medical laboratory training programs and students graduating from such programs in U.S.

Lack of trained graduates and training programs is an issue particularly in developing countries, where demand for skilled professionals is rapidly increasing. However, entry of automated systems in the market is going to replace manually-operated conventional platforms in future, thereby reducing the impact of lack of skilled professionals.

Product Insights

Reagents accounted for the largest revenue share in the global clinical microbiology market. The segment includes products such as solutions, primers, master mixes, and kits used in various diagnostic assays. Reagents currently captures the largest revenue share, with more than 60% attributed to repeat purchase driven by need for new set of reagents for new tests.

The segment is expected to remain dominant throughout the forecast period. Factors such as higher cost of specialized kits and constant repeat purchase are expected to drive the segment over the forecast period. The market is witnessing rising investments in research and development (R&D). Almost all analytical and therapeutic research projects demand reagents and chemicals, thereby driving penetration of reagents.

Global clinical microbiology market share

Laboratory instruments comprise incubators, gram strainers, bacterial colony counters, autoclave sterilizers, petri dish fillers, and culture systems. Automated culture systems dominated the global laboratory instruments segment with more than 30% share in 2016.

The microbiology analyzers segment comprises instruments used in molecular diagnostics, mass spectrometry, and microscopes. Microscopes held the largest share owing to wider applicability and rising demand. The molecular diagnostic instruments segment, on the other hand, is expected to exhibit the fastest growth rate over the forecast period. This growth can be attributed to increasing significance of molecular diagnosis in early detection of cancer and infectious diseases.

Application Insights

Increasing levels of air pollution with growing industrialization is resulting in rapid escalation in prevalence of respiratory diseases. Also, among all infections, respiratory diseases spread rapidly owing to easy transfer of contagious pathogens. Thus, the segment is expected to show significant growth over the forecast period. Furthermore, prevalence of infectious diseases is high in developed as well as developing countries.

In addition, according to a few investigations recently published in the Journal of the American Medical Association, chronic respiratory diseases were responsible for about 1 in 15 deaths in 2015. Approximately USD 132 billion of healthcare spending was associated with these diseases in 2013. Biopsy, blood tests, and bronchoscopy are the most commonly used diagnostic tools for respiratory diseases. Therefore, rising incidence of chronic respiratory diseases is boosting market growth. 

Regional Insights

North America accounted for the largest revenue share in 2016 and was closely followed by Europe. Highly developed industrial and healthcare sectors in U.S. are fueling adoption of advanced clinical diagnostic techniques. In addition, stringent regulatory framework and presence of leading players are augmenting regional market growth.

Asia Pacific is expected to be the fastest growing region from 2016 to 2024. Japan is one of the leading countries with strong technological developments and high usage of microbial testing for various applications. China is another significant market contributing to regional growth.

Booming medical tourism industry is expected to spur demand for microbial diagnostic and monitoring tests in Asian countries such as India, China, Thailand, and Malaysia. Furthermore, availability of skilled labor at affordable cost and advanced manufacturing infrastructure are resulting in manufacturing facilities of major pharmaceutical and medical device makers shifting to Asia. This is boosting regional market expansion.

Clinical Microbiology Market Share Insights

The market is presently dominated by a few key participants such as bioMerieux S.A.; Cepheid Inc.; Danaher Corporation; and Bruker Corporation. Other prominent players operating in the market include but are not limited to Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics; and Alere Inc. Introduction of automated systems and innovative designs is expected to intensify the competition by changing market dynamics over the forecast period.

Clinical Microbiology Market Report Scope

Report Attribute


Market size value in 2020

USD 12.4 billion

Revenue forecast in 2025

USD 16.7 billion

Growth Rate

CAGR of 6.7% from 2017 to 2025

Base year for estimation


Historical data

2014 - 2015

Forecast period

2017 - 2025

Quantitative units

Revenue in USD Million & CAGR from 2017 to 2025

Report coverage

Revenue forecast; company share; competitive landscape; growth factors and trends

Segments covered

Product, application, region

Country scope

U.S.; Canada; U.K.; Germany; China; India; Brazil; Mexico; & South Africa

Key companies profiled

bioMerieux S.A.; Cepheid Inc.; Danaher Corporation; Bruker Corporation; Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics; Alere Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country; regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global clinical microbiology market report on the basis of product, application, and region:

  • Product Outlook (Revenue, USD Million, 2014 - 2025)

    • Laboratory Instruments

      • Incubators

      • Gram Stainers

      • Bacterial Colony Counters

      • Autoclave Sterilizers

      • Petri Dish Fillers

    • Automated Culture Systems

      • Microbiology Analyzers

      • Molecular Diagnostic Instruments

      • Microscopes

      • Mass Spectrometers

    • Reagents

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Respiratory Diseases

    • Bloodstream Infections

    • Gastrointestinal Diseases

    • Sexually Transmitted Diseases

    • Urinary Tract Infections

    • Periodontal Diseases

    • Other Diseases

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • China

      • India

      • Japan

    • Latin America

      • Mexico

      • Brazil

    • Middle East & Africa

      • South Africa

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon